Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The change is a minor version update (v3.4.2 replacing v3.4.1) and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T11:32:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new page revision, v3.4.1, was added and the previous revision v3.4.0 was removed; this appears to be a backend/UI version update rather than a change to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T07:41:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and site revision information (v3.4.0) along with the updated 'Last Update Submitted that Met QC Criteria' label. The previous wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T05:41:15.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page. There are no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:20:32.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Texas as a study site. The previous Texas Locations entry was removed and the page revision updated to v3.3.3 (HHS Vulnerability Disclosure link removed).
    Difference
    0.2%
    Check dated 2025-12-23T20:43:56.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Publications section now displays auto-filled PubMed notes and includes a new revision label (v3.3.2). The older PubMed-source description was removed and replaced with the updated revision tag (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-25T10:24:56.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.